apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...
Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...
AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...
Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...
AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...
China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...
Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...
The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...
Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...
China based BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innova...
US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...
Roche has announced that the European Commission has approved Kadcyla® (trastuzumab emtansine) for the adjuvant (aft...
Pfizer and Japan based Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved a su...
AstraZeneca and Daiichi Sankyo Company presented positive detailed data from the global pivotal Phase II single-arm DEST...
Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in Chi...
Innovent Biologics, a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Ty...
Chugai Pharmaceutical has announced that the "New England Journal of Medicine" (NEJM) online edition November 27 R...
Astellas Pharma Inc., based in Tokyo, Japan has announced the China National Medical Products Administration ...
